urea has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dykstra, H; Fan, S; Mercer, AJ; Papugani, A; Persidsky, Y; Ramirez, SH; Reichenbach, N; Tuma, RF; Zhang, M | 1 |
| Dawson, LA; Kalinichev, M | 1 |
2 other study(ies) available for urea and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
| Article | Year |
|---|---|
Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.
Topics: AIDS Dementia Complex; Animals; Blood-Brain Barrier; Brain; Case-Control Studies; Cell Adhesion; Cells, Cultured; Drug Evaluation, Preclinical; Encephalitis; Endothelial Cells; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Monocytes; Protein Kinase Inhibitors; Thiadiazoles; Thiazoles; Urea | 2010 |
Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Topics: Amphetamine; Animals; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Blood-Brain Barrier; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glycogen Synthase Kinase 3; Humans; Indoles; Male; Maleimides; Mice; Mice, Mutant Strains; Molecular Targeted Therapy; Motor Activity; Reproducibility of Results; Thiadiazoles; Thiazoles; Urea | 2011 |